1. RISK‐ADAPTED THERAPY IN ADULTS WITH BURKITT LYMPHOMA: UPDATED RESULTS OF a MULTICENTER PROSPECTIVE PHASE II STUDY OF DA‐EPOCH‐R. (June 2017) Authors: Dunleavy, K.; Roschewski, M.; Abramson, J.S.; Link, B.; Parekh, S.; Jagadeesh, D.; Bierman, P.; Watson, P.R.; Peace, D.; Hanna, W.; Powell, B.; Melani, C.; Lucas, A.; Steinberg, S.M.; Kahl, B.; Friedberg, J.W.; Little, R.F.; Bartlett, N.L.; Fanale, M.A.; Noy, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAFETY AND PRELIMINARY EFFICACY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA RECEIVING LISOCABTAGENE MARALEUCEL IN TRANSCEND NHL 001. (12th June 2019) Authors: Wang, M.; Gordon, L.I.; Palomba, M.L.; Abramson, J.S.; Andreadis, C.; Ghosh, N.; Lunning, M.; Maloney, D.; Farazi, T.; Garcia, J.; Xie, B.; Newhall, K.; Dehner, C.; Siddiqi, T. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAFETY OF LISOCABTAGENE MARALEUCEL GIVEN WITH DURVALUMAB IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B‐CELL NON HODGKIN LYMPHOMA: FIRST RESULTS FROM THE PLATFORM STUDY. (12th June 2019) Authors: Siddiqi, T.; Abramson, J.S.; Lee, H.J.; Schuster, S.; Hasskarl, J.; Montheard, S.; Dell Aringa, J.; Thompson, E.; Ananthakrishnan, R.; Lunning, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗